Diurnal Ltd

Diurnal Ltd

Diurnal is an innovative pharmaceutical, venture capital-backed, company that creates high-value hormone therapeutics using proprietary formulations and novel physiological treatment regimens of approved drugs.

 

Diurnal addresses the major unmet clinical and patient needs for hormone replacement treatments by creating more effective products for life-long treatment for chronic conditions, including adrenal insufficiency, rheumatoid arthritis, hypogonadism, and hypothryroidism.

 

Diurnal's lead therapy is Chronocort® (circadian hydrocortisone) for the treatment of Congenital Adrenal Hyperplasia and Adrenal Insufficiency in adults.

 

www.diurnal.co.uk